CLDN4 and glioblastoma: In order to further study the anticancer effect of inhibiting CLDN4 expression on GBM progression in vivo, xenograft models were established by intracranial injection of luciferase-labeled CLDN4 NC or shCLDN4 U87 cells, which were directly inoculated into the lateral ventricle of nude mice.